ARS Pharmaceuticals, Inc.（SPRY）内部人交易：高管与董事近期交易
过去 18 个月，共有 15 位内部人为 ARS Pharmaceuticals, Inc.（SPRY）报告了 37 笔 Form 4 交易（最近一笔 2026-06-12）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-06-12 | Karas Eric | Chief Commercial Officer | 买入 | 25,000 | $37,500 |
| 2026-06-12 | Karas Eric | Chief Commercial Officer | 卖出 | 25,000 | $250,000 |
| 2026-06-12 | Fitzpatrick Alexander A | Chief Legal Officer | 卖出 | 3,355 | $33,550 |
| 2025-11-14 | Shah Pratik | 董事 | 卖出 | 250,000 | $0 |
| 2025-11-14 | Shah Pratik | 董事 | 卖出 | 100,000 | $0 |
| 2025-11-14 | Chakma Justin | Chief Business Officer | 买入 | 30,000 | $25,200 |
| 2025-11-14 | Chakma Justin | Chief Business Officer | 卖出 | 30,000 | $267,300 |
| 2025-11-14 | Chakma Justin | Chief Business Officer | 卖出 | 136,380 | $1.2M |
| 2025-11-14 | Dorsey Brian | Chief Operating Officer | 买入 | 21,828 | $13,970 |
| 2025-11-14 | Dorsey Brian | Chief Operating Officer | 卖出 | 21,828 | $190,122 |
| 2025-08-22 | Lowenthal Richard E | PRESIDENT AND CEO | 卖出 | 50,000 | $724,500 |
| 2025-08-22 | Scott Kathleen D. | Chief Financial Officer | 卖出 | 12,500 | $187,500 |
| 2025-08-22 | Scott Kathleen D. | Chief Financial Officer | 买入 | 12,500 | $18,750 |
| 2025-08-21 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | 卖出 | 12,344 | $173,186 |
| 2025-08-21 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | 卖出 | 37,656 | $530,573 |
| 2025-07-03 | Karas Eric | Chief Commercial Officer | 买入 | 15,000 | $22,500 |
| 2025-07-03 | Karas Eric | Chief Commercial Officer | 卖出 | 15,000 | $254,850 |
| 2025-07-01 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10% 以上股东 | 卖出 | 370,075 | $6.8M |
| 2025-07-01 | Flynn James E | 10% 以上股东 | 卖出 | 370,075 | $6.8M |
| 2025-07-01 | Deerfield Private Design Fund III, L.P. | 10% 以上股东 | 卖出 | 370,075 | $6.8M |
| 2025-07-01 | Deerfield Mgmt III, L.P. | 10% 以上股东 | 卖出 | 370,075 | $6.8M |
| 2025-07-01 | Deerfield Private Design Fund IV, L.P. | 10% 以上股东 | 卖出 | 370,075 | $6.8M |
| 2025-07-01 | Deerfield Mgmt IV, L.P. | 10% 以上股东 | 卖出 | 370,075 | $6.8M |
| 2025-07-01 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10% 以上股东 | 卖出 | 370,074 | $6.8M |
| 2025-07-01 | Flynn James E | 10% 以上股东 | 卖出 | 370,074 | $6.8M |
来源：SEC Form 4 申报文件 · 截至 2026-06-12